Trial Profile
A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch for Clinical Islet Transplantation
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Islet cell replacement therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Sernova Corp
- 02 Apr 2024 Results published in the Sernova Corp Media Release
- 29 Jan 2024 Anticipates additional data from According to a Sernova Corp media release, company aniticipates Cohort 2 of Phase 1/2 clinical trial evaluating its enhanced 10-channel Cell Pouch in patients with type 1 diabetes (T1D) in Q1/24.
- 29 Jan 2024 According to a Sernova Corp media release, recruitment of all 7 patients in Cohort 2 was recently completed.